Impact of ERAS Protocol on Length of Hospital Stay After Laparoscopic Surgeries
Impact of Multimodal Analgesia and ERAS Protocol on Length of Hospital Stay After Laparoscopic Gynecological Surgeries: A Randomized Control Trial
Aga Khan University
98 participants
Aug 20, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to determine the length of hospital stay in patients using multimodal analgesia with or without ERAS protocol scheduled for elective laparoscopic gynecological surgeries
Eligibility
Inclusion Criteria2
- ASA physical status I, II, and III
- Patients scheduled for elective laparoscopic gynecological surgeries
Exclusion Criteria5
- Refusal to participate
- History of allergy or contraindication to study drugs
- Patients in which procedure converted to open surgery
- Diagnostic laparoscopic procedures
- Patients with a history of severe anxiety or depression
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Preoperatively ERAS protocol includes, No solid food for 6 hours before procedure; 800 ml (fantomalt powder) Carbohydrate drink 8 hours before surgery; 400 ml (fantomalt powder) 2 hours before surgery; Celecoxib 200g 1 hour before surgery . Intraoperatively, on induction lidocaine 1.5 mg/kg and Fentanyl 1 to 2 mcg/kg followed by IV lidocaine infusion at 1.5 mg/kg/h.
Preoperatively, NPO 6 hours before the procedure Intraoperatively, on induction Nabuphine 0.1mg/kg
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07116564